Production and separation of 43Sc for radiopharmaceutical purposes
Abstract Background The favorable decay properties of 43Sc and 44Sc for PET make them promising candidates for future applications in nuclear medicine. An advantage 43Sc (T1/2 = 3.89 h, Eβ+ av = 476 keV [88%]) exhibits over 44Sc, however, is the absence of co-emitted high energy γ-rays. While the pr...
Saved in:
Main Authors: | Katharina A. Domnanich (Author), Robert Eichler (Author), Cristina Müller (Author), Sara Jordi (Author), Vera Yakusheva (Author), Saverio Braccini (Author), Martin Behe (Author), Roger Schibli (Author), Andreas Türler (Author), Nicholas P. van der Meulen (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2017-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
44Sc for labeling of DOTA- and NODAGA-functionalized peptides: preclinical in vitro and in vivo investigations
by: Katharina A. Domnanich, et al.
Published: (2016) -
47Sc as useful β--emitter for the radiotheragnostic paradigm: a comparative study of feasible production routes
by: Katharina A. Domnanich, et al.
Published: (2017) -
Therapeutic Potential of <sup>47</sup>Sc in Comparison to <sup>177</sup>Lu and <sup>90</sup>Y: Preclinical Investigations
by: Klaudia Siwowska, et al.
Published: (2019) -
Alpha-PET with terbium-149: evidence and perspectives for radiotheragnostics
by: Cristina Müller, et al.
Published: (2016) -
Guidance on validation and qualification of processes and operations involving radiopharmaceuticals
by: S. Todde, et al.
Published: (2017)